Abstract
A variety of ethyleneglycol‐type nonphosphorus alkyl ether lipids, ether derivatives of diethylene‐glycol in which the two hydroxyl groups were substituted with long chain alkyl and quaternary ammonioalkyl groups, were synthesized and their effects on proliferation and differentiation of cultured human (HL‐60) and mouse (M1) myeloid leukemia cells were studied. Incubation with these compounds inhibited the cellular proliferation, and the cells differentiated into morphologically and functionally mature granulocytes. Of the compounds tested, 1‐[2‐[2‐(octadecyloxy)ethoxy]ethoxy]‐butylpyridinium mesylate (EG‐6) was the most effective in inducing differentiation of HL‐60 cells. Almost maximal induction of differentiation and inhibition of growth of HL‐60 cells on day 6 were observed when the cells were treated with EG‐6 for 1 day and then cultured without EG‐6 for a further 5 days. The inhibitory effect of EG‐6 on the leukemic cells was over 100 times more than that of 2‐[2‐(dodecyloxy)ethoxy]ethyl 2‐pyridinioethyl phosphate, a potent antileukemic ether phospholipid.
Keywords: Differentiation, Growth inhibition, Myeloid leukemia, HL‐60 cells, Alkyl ether lipids
Full Text
The Full Text of this article is available as a PDF (341.6 KB).
REFERENCES
- 1. ) Andreesen , R. , Modolell , M. and Munder , P. G.Selective sensitivity of chronic myelogenous leukemia cell population to alkyl‐lysophospholipids . Blood , 54 , 519 – 523 ( 1979. ). [PubMed] [Google Scholar]
- 2. ) Andreesen , R. , Modolell , M. , Weltzien , H. U. , Eibl , H. , Common , H. , Lohr , G. W. and Munder , P. G.Selective destruction of human leukemic cells by alky‐lysophos‐pholipids . Cancer Res. , 38 , 3894 – 3899 ( 1978. ). [PubMed] [Google Scholar]
- 3. ) Modolell , M. , Andreesen , R. , Pahlke , W. , Brugger , U. and Munder , P. G.Disturbance of phospholipid metabolism during selective destruction of tumor cells induced by alkyl‐lysophospholipids . Cancer Res. , 39 , 4681 – 4686 ( 1979. ). [PubMed] [Google Scholar]
- 4. ) Fleer , E. A. M. , Unger , C. and Eibl , H.Metabolism of ether phospholipids and analogs in neoplastic cells . Lipids , 22 , 856 – 861 ( 1987. ). [DOI] [PubMed] [Google Scholar]
- 5. ) Wilcox , R. W. , Wykle , R. L. , Schmitt , J. D. and Daniel , L. W.The degradation of platelet‐activating factor and related lipids: susceptibility to phospholipases C and D . Lipids , 22 , 800 – 807 ( 1987. ). [DOI] [PubMed] [Google Scholar]
- 6. ) Berdel , W. E. , Bausert , W. R. E. , Fink , R. , Rastetter , J. and Munder , P. G.Anti‐tumor action of alkyl‐lysophospholipids (review) . Anticancer Res. , 1 , 345 – 352 ( 1981. ). [PubMed] [Google Scholar]
- 7. ) Hanahan , D. J. , Munder , P. G. , Satouchi , K. , McManus , L. and Pinckard , R. N.Potent platelet stimulating activity of enantiomers of acetyl glyceryl ether phosphorylcholine and its methoxy analogues . Biochem. Biophys. Res. Commun. , 99 , 183 – 188 ( 1981. ). [DOI] [PubMed] [Google Scholar]
- 8. ) Berdel , W. E. , Andreesen , R. and Munder , P. G. “ Phospholipids and Cellular Regulation ,” vol. 2 , ed. Kuo J. F. , pp. 41 – 73 ( 1985. ). CRC Press; , Florida . [Google Scholar]
- 9. ) Neumann , H. A. , Herrmann , D. B. J. and Boerner , D.Inhibition of human tumor colony formation by the new alkyl lysophospholipid Ilmofosine . J. Natl. Cancer Inst. , 78 , 1087 – 1093 ( 1987. ). [PubMed] [Google Scholar]
- 10. ) Hilgard , P. , Stekar , J. , Voegeli , R. , Engel , J. , Schumacher , W. , Eibl , H. , Unger , C. and Berger , M. R.Characterization of the antitumor activity of hexadecylphosphocholine (D 18506) . Eur. J. Cancer Clin. Oncol. , 24 , 1457 – 1461 ( 1988. ). [DOI] [PubMed] [Google Scholar]
- 11. ) Honma , Y. , Kasukabe , T. , Hozumi , M. , Tsushima , S. and Nomura , H.Induction of differentiation of cultured human and mouse myeloid leukemia cells by alkyl‐lysophospholipids . Cancer Res. , 41 , 3211 – 3216 ( 1981. ). [PubMed] [Google Scholar]
- 12. ) Honma , Y. , Kasukabe , T. , Okabe‐Kado , J. , Hozumi , M. , Tsushima , S. and Nomura , H.Antileukemic effect of alkyl phospholipids I. Inhibition of proliferation of cultured myeloid leukemia cells by alkyl ethyleneglycophospho‐lipids . Cancer Chemother. Pharmacol. , 11 , 73 – 76 ( 1983. ). [DOI] [PubMed] [Google Scholar]
- 13. ) Honma , Y. , Kasukabe , T. , Okabe‐Kado , J. , Hozumi , M. , Tsushima , S. and Nomura , H.Antileukemic effect of alkyl phospholipids II. Prolongation of survival times of leukemic mice by alkyl ethyleneglycophospholipids . Cancer Chemother. Pharmacol. , 11 , 77 – 79 ( 1983. ). [DOI] [PubMed] [Google Scholar]
- 14. ) Ukawa , K. , Imamiya , E. , Yamamoto , H. , Mizuno , K. , Tasaka , A. , Terashita , Z. , Okutani , T. , Nomura , H. , Kasukabe , T. , Hozumi , M. , Kudo , I. and Inoue , K.Synthesis and antitumor activity of new alkylphospholipids containing modifications of the phosphocholine moiety . Chem. Pharm. Bull. , 37 , 1249 – 1255 ( 1989. ). [DOI] [PubMed] [Google Scholar]
- 15. ) Ukawa , K. , Imamiya , E. , Yamamoto , H. , Aono , T. , Kozai , Y. , Okutani , T. , Nomura , H. , Honma , Y. , Hozumi , M. , Kudo , I. and Inoue , K.Synthesis and antitumor activity of new amphiphilic alkylglycerolipids substituted with a polar head group, 2‐(2‐trimethylammonioethoxy)‐ethyl or a congeneric oligo(ethyleneoxy)ethyl group . Chem. Pharm. Bull. , 37 , 3277 – 3285 ( 1989. ). [DOI] [PubMed] [Google Scholar]
- 16. ) Collins , S. J. , Gallo , R. C. and Gallagher , R. E.Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture . Nature , 270 , 347 – 349 ( 1977. ). [DOI] [PubMed] [Google Scholar]
- 17. ) Lozzio , C. B. and Lozzio , B. B.Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome . Blood , 45 , 321 – 334 ( 1975. ). [PubMed] [Google Scholar]
- 18. ) Ichikawa , Y.Differentiation of a cell line of myeloid leukemia . J. Cell. Physiol. , 74 , 223 – 234 ( 1969. ). [DOI] [PubMed] [Google Scholar]
- 19. ) Hozumi , M.Fundamentals of chemotherapy of myeloid leukemia by induction of leukemia cell differentiation . Adv. Cancer Res. , 38 , 121 – 169 ( 1983. ). [DOI] [PubMed] [Google Scholar]
- 20. ) Kasukabe , T. , Honma , Y. and Hozumi , M.Induction of differentiation of cultured mouse monocytic leukemia cells (Mm‐A) by inducers different from those of parent myeloblastic leukemia cells (M1) . Jpn. J. Cancer Res. , 76 , 1056 – 1063 ( 1985. ). [PubMed] [Google Scholar]
- 21. ) Takuma , T. , Takeda , K. and Konno , K.Synergism of tumor necrosis factor and interferon‐γ in induction of differentiation of human myeloblastic leukemic ML‐1 cells . Biochem. Biophys. Res. Commun. , 145 , 514 – 521 ( 1987. ). [DOI] [PubMed] [Google Scholar]
- 22. ) Tidwell , T. , Guzman , G. and Vogler , W.The effects of alkyl‐lysophospholipids on leukemic cell lines. I. Differential action on two human leukemic cell lines, HL60 and K562 . Blood , 57 , 794 – 797 ( 1981. ). [PubMed] [Google Scholar]
- 23. ) Tenforde , T. S. , Adesida , P. O. , Kelly , L. S. and Todd , P. W.Differing electrical surface charge and transplantation properties of genetically variant sublines of the TA3 murine adenocarcinoma tumor . Eur. J. Cancer Clin. Oncol. , 19 , 277 – 282 ( 1983. ). [DOI] [PubMed] [Google Scholar]
- 24. ) Hoffman , D. R. , Hoffman , L. H. and Snyder , F.Cytotoxicity and metabolism of alkyl phospholipid analogues in neoplastic cells . Cancer Res. , 46 , 5803 – 5809 ( 1986. ). [PubMed] [Google Scholar]
- 25. ) Daniel , L. W. , Small , G. W. and Strum , J. C.Characterization of cells sensitive and resistant to ET‐18‐OCH3 . Proc. Am. Assoc. Cancer Res. , 31 , 412 ( 1990. ). [Google Scholar]
- 26. ) Fleer , E. A. M. , Berkovic , D. , Eibl , H. and Unger , C.Cellular uptake of hexadecylphosphocholine (He‐PC) . Proc. Am. Assoc. Cancer Res. , 31 , 414 ( 1990. ). [Google Scholar]